Sheheryar Kabraji, Associate Professor at
“! Very cool story re-examining how to combine endocrine and chemotherapy in ER+ breast cancer with cool use of the MPI index.
Look at how ER low tumors behave!
Congrats Albert Grinshpun, RM Jesel, Sandro Santagata, Dana-Farber Cancer Institute and Harvard Program in Therapeutic Science.”
Visit the article website.
Source: Sheheryar Kabraji/X